Form 4: Director Shari Lisa Pire Reports Vesting of Restricted Stock Units in Precision BioSciences Inc (DTIL)
SEC Form 4 Filing
Director Shari Lisa Pire reports the vesting and settlement of 4,202 Restricted Stock Units (RSUs) into common stock of Precision BioSciences Inc on May 4, 2024.
Summary
- On May 4, 2024, Shari Lisa Pire, a director of Precision BioSciences Inc (DTIL), had 4,202 Restricted Stock Units (RSUs) vest and settle.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The RSUs vested in full on May 4, 2024.
- The amounts of securities herein have been adjusted to reflect the reverse stock split.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting the standard vesting of previously granted equity compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of RSUs is a common form of equity compensation.
Stakeholder Impact
- The vesting of RSUs increases the number of shares outstanding, which could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/04/2023 | Reporting Person was granted RSUs |
| 02/13/2024 | Issuer effected a 1-for-30 reverse stock split |
| 05/04/2024 | Restricted Stock Units vested and settled |
| 05/07/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.